ANTX - AN2 Therapeutics Inc Market Cap to Sales Volume

Corporate company logo of AN2 Therapeutics, Inc. (ANTX)

Complex thermologistics of drugs and capital outflow due to a pause in Phase III trials are putting pressure on AN2 Therapeutics, Inc. (ANTX). The P/S ratio history clearly demonstrates the market reaction, where determines the current value of the metric. The business is based on a unique boron ecosystem that forms a closed patent perimeter and creates significant barriers to switching therapies.

AN2 Therapeutics, Inc. (ANTX): Price-to-Revenue Ratio from 07/04/2022 to 11/17/2026

Metric breakdowns and analytics for AN2 Bio (ANTX)

- market price and analyst price targets:
- market capitalization statistics:
General company analysis:ANTX AN2 Therapeutics, Inc.
Manufactured products of AN2 Therapeutics Inc

The P/S multiple relates the market value of a business to its annual revenue, determining the price per unit of income generated. For AN2 Therapeutics, Inc. (ANTX), this calculation is critical, as the suspension of Phase III trials and pressure from the FDA undermine confidence in future sales. By analyzing historical P/S levels, an investor can identify asset overvaluation amid capital outflows. A decline in this metric signals an increase in potential yield but warns of the risk of waning demand.